Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2026 · third_quarter · Q3
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS (DRAFT) CLINICAL TRIAL MODERNIZATION ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; PROVISIONS RELATED TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION (FDA) AND RELATED AGENCIES, CENTERS FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH (NIH) AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION OPPOSING OFFICE OF MANAGEMENT AND BUDGET'S (OMB) PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE (RELEASED 5/29/26) CFF SUBMITS COMMENTS TO ORGAN PROCUREMENT & TRANSPLANT NETWORK (OPTN)/HEALTH RESOURCES & SERVICES ADMINISTRATION (HRSA) IN RESPONSE TO OPTN'S UPDATE ON LUNG CONTINUOUS DISTRIBUTION POLICY PROPOSAL CFF SUBMITS COMMENTS IN RESPONSE TO A REQUEST FOR INFORMATION (RFI) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) ON EXPEDITED INVESTIGATIONAL NEW DRUG PILOT PROGRAM CFF SUBMITS COMMENTS TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) IN RESPONSE TO PROPOSED REGULATION ON CLINICAL TRIALS CFF SUBMITS COMMENT TO FOOD AND DRUG ADMINISTRATION (FDA) IN RESPONSE TO DRAFT GUIDANCE ON LEVERAGING PRIOR KNOWLEDGE IN THE DEVELOPMENT OF HUMAN GENE THERAPY PRODUCTS INCORPORATING GENOME EDITING
Source: Senate LDA
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS (DRAFT) CLINICAL TRIAL MODERNIZATION ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; PROVISIONS RELATED TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION (FDA) AND RELATED AGENCIES, CENTERS FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH (NIH) AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION OPPOSING OFFICE OF MANAGEMENT AND BUDGET'S (OMB) PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE (RELEASED 5/29/26) CFF SUBMITS COMMENTS TO ORGAN PROCUREMENT & TRANSPLANT NETWORK (OPTN)/HEALTH RESOURCES & SERVICES ADMINISTRATION (HRSA) IN RESPONSE TO OPTN'S UPDATE ON LUNG CONTINUOUS DISTRIBUTION POLICY PROPOSAL CFF SUBMITS COMMENTS IN RESPONSE TO A REQUEST FOR INFORMATION (RFI) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) ON EXPEDITED INVESTIGATIONAL NEW DRUG PILOT PROGRAM CFF SUBMITS COMMENTS TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) IN RESPONSE TO PROPOSED REGULATION ON CLINICAL TRIALS CFF SUBMITS COMMENT TO FOOD AND DRUG ADMINISTRATION (FDA) IN RESPONSE TO DRAFT GUIDANCE ON LEVERAGING PRIOR KNOWLEDGE IN THE DEVELOPMENT OF HUMAN GENE THERAPY PRODUCTS INCORPORATING GENOME EDITING
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
PBM Reform Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION
PBM Reform Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
PBM Reform Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
PBM Reform Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS SURROUNDING FY2027 APPROPRIATIONS; PROVISIONS RELATED TO NATIONAL INSTITUTE OF HEALTH AND FOOD AND DRUG ADMINISTRATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS (DRAFT) CLINICAL TRIAL MODERNIZATION ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; PROVISIONS RELATED TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION (FDA) AND RELATED AGENCIES, CENTERS FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH (NIH) AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION OPPOSING OFFICE OF MANAGEMENT AND BUDGET'S (OMB) PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE (RELEASED 5/29/26) CFF SUBMITS COMMENTS TO ORGAN PROCUREMENT & TRANSPLANT NETWORK (OPTN)/HEALTH RESOURCES & SERVICES ADMINISTRATION (HRSA) IN RESPONSE TO OPTN'S UPDATE ON LUNG CONTINUOUS DISTRIBUTION POLICY PROPOSAL CFF SUBMITS COMMENTS IN RESPONSE TO A REQUEST FOR INFORMATION (RFI) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) ON EXPEDITED INVESTIGATIONAL NEW DRUG PILOT PROGRAM CFF SUBMITS COMMENTS TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) IN RESPONSE TO PROPOSED REGULATION ON CLINICAL TRIALS CFF SUBMITS COMMENT TO FOOD AND DRUG ADMINISTRATION (FDA) IN RESPONSE TO DRAFT GUIDANCE ON LEVERAGING PRIOR KNOWLEDGE IN THE DEVELOPMENT OF HUMAN GENE THERAPY PRODUCTS INCORPORATING GENOME EDITING
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS
SUPER BUGS Act of 2026
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
SUPER BUGS Act of 2026
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
SUPER BUGS Act of 2026
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS SURROUNDING FY2027 APPROPRIATIONS; PROVISIONS RELATED TO NATIONAL INSTITUTE OF HEALTH AND FOOD AND DRUG ADMINISTRATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
SUPER BUGS Act of 2026
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS
PBM Kickback Prohibition Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
PBM Kickback Prohibition Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS (DRAFT) CLINICAL TRIAL MODERNIZATION ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; PROVISIONS RELATED TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION (FDA) AND RELATED AGENCIES, CENTERS FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH (NIH) AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION OPPOSING OFFICE OF MANAGEMENT AND BUDGET'S (OMB) PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE (RELEASED 5/29/26) CFF SUBMITS COMMENTS TO ORGAN PROCUREMENT & TRANSPLANT NETWORK (OPTN)/HEALTH RESOURCES & SERVICES ADMINISTRATION (HRSA) IN RESPONSE TO OPTN'S UPDATE ON LUNG CONTINUOUS DISTRIBUTION POLICY PROPOSAL CFF SUBMITS COMMENTS IN RESPONSE TO A REQUEST FOR INFORMATION (RFI) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) ON EXPEDITED INVESTIGATIONAL NEW DRUG PILOT PROGRAM CFF SUBMITS COMMENTS TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) IN RESPONSE TO PROPOSED REGULATION ON CLINICAL TRIALS CFF SUBMITS COMMENT TO FOOD AND DRUG ADMINISTRATION (FDA) IN RESPONSE TO DRAFT GUIDANCE ON LEVERAGING PRIOR KNOWLEDGE IN THE DEVELOPMENT OF HUMAN GENE THERAPY PRODUCTS INCORPORATING GENOME EDITING
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS (DRAFT) CLINICAL TRIAL MODERNIZATION ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; PROVISIONS RELATED TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION (FDA) AND RELATED AGENCIES, CENTERS FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH (NIH) AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION OPPOSING OFFICE OF MANAGEMENT AND BUDGET'S (OMB) PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE (RELEASED 5/29/26) CFF SUBMITS COMMENTS TO ORGAN PROCUREMENT & TRANSPLANT NETWORK (OPTN)/HEALTH RESOURCES & SERVICES ADMINISTRATION (HRSA) IN RESPONSE TO OPTN'S UPDATE ON LUNG CONTINUOUS DISTRIBUTION POLICY PROPOSAL CFF SUBMITS COMMENTS IN RESPONSE TO A REQUEST FOR INFORMATION (RFI) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) ON EXPEDITED INVESTIGATIONAL NEW DRUG PILOT PROGRAM CFF SUBMITS COMMENTS TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) IN RESPONSE TO PROPOSED REGULATION ON CLINICAL TRIALS CFF SUBMITS COMMENT TO FOOD AND DRUG ADMINISTRATION (FDA) IN RESPONSE TO DRAFT GUIDANCE ON LEVERAGING PRIOR KNOWLEDGE IN THE DEVELOPMENT OF HUMAN GENE THERAPY PRODUCTS INCORPORATING GENOME EDITING
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT: ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL STATEMENT ON ANNOUNCEMENT BY NIH THAT IT WILL SET THE REIMBURSEMENT RATE FOR INDIRECT COSTS TO 15% TO BOTH EXISTING AND NEW GRANTS COMMENTS IN RESPONSE TO DRAFT GUIDANCE ON THE USE OF MEDICAL-GRADE PULSE OXIMETERS GENERAL DISCUSSIONS SURROUNDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH (NIH)
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Mikaela Naylon Give Kids a Chance Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH (NIH) GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION STATEMENT ON ANNOUNCEMENT BY NIH THAT IT WILL SET THE REIMBURSEMENT RATE FOR INDIRECT COSTS TO 15% TO BOTH EXISTING AND NEW GRANTS COMMENTS IN RESPONSE TO DRAFT GUIDANCE ON THE USE OF MEDICAL-GRADE PULSE OXIMETERS
Regulations from the Executive in Need of Scrutiny Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 77: MIDNIGHT RULES RELIEF ACT; ALL PROVISIONS H.R. 142: REGULATIONS FROM THE EXECUTIVE IN NEED OF SCRUTINY (REINS) ACT OF 2025; ALL PROVISIONS H.R. 1515: GUIDANCE OUT OF DARKNESS (GOOD) ACT; ALL PROVISIONS S. 164: MIDNIGHT RULES RELIEF ACT OF 2025; ALL PROVISIONS S. 252: GUIDANCE OUT OF DARKNESS (GOOD) ACT; ALL PROVISIONS STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION
Regulations from the Executive in Need of Scrutiny Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 142: REGULATIONS FROM THE EXECUTIVE IN NEED OF SCRUTINY (REINS) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH (NIH) GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION STATEMENT ON ANNOUNCEMENT BY NIH THAT IT WILL SET THE REIMBURSEMENT RATE FOR INDIRECT COSTS TO 15% TO BOTH EXISTING AND NEW GRANTS COMMENTS IN RESPONSE TO DRAFT GUIDANCE ON THE USE OF MEDICAL-GRADE PULSE OXIMETERS
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT: ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
Accelerating Kids’ Access to Care Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 77: MIDNIGHT RULES RELIEF ACT; ALL PROVISIONS H.R. 142: REGULATIONS FROM THE EXECUTIVE IN NEED OF SCRUTINY (REINS) ACT OF 2025; ALL PROVISIONS H.R. 1515: GUIDANCE OUT OF DARKNESS (GOOD) ACT; ALL PROVISIONS S. 164: MIDNIGHT RULES RELIEF ACT OF 2025; ALL PROVISIONS S. 252: GUIDANCE OUT OF DARKNESS (GOOD) ACT; ALL PROVISIONS STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION
Insurance Fraud Accountability Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Insurance Fraud Accountability Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
Insurance Fraud Accountability Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
Insurance Fraud Accountability Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Insurance Fraud Accountability Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Insurance Fraud Accountability Act
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH (NIH) GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION STATEMENT ON ANNOUNCEMENT BY NIH THAT IT WILL SET THE REIMBURSEMENT RATE FOR INDIRECT COSTS TO 15% TO BOTH EXISTING AND NEW GRANTS COMMENTS IN RESPONSE TO DRAFT GUIDANCE ON THE USE OF MEDICAL-GRADE PULSE OXIMETERS
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH (NIH) GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION STATEMENT ON ANNOUNCEMENT BY NIH THAT IT WILL SET THE REIMBURSEMENT RATE FOR INDIRECT COSTS TO 15% TO BOTH EXISTING AND NEW GRANTS COMMENTS IN RESPONSE TO DRAFT GUIDANCE ON THE USE OF MEDICAL-GRADE PULSE OXIMETERS
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Health Care Affordability Act of 2025
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT: ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
GENERAL DISCUSSION ON DRUG PRICING REFORM
GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION GENERAL DISCUSSION OPPOSING OFFICE OF MANAGEMENT AND BUDGET'S (OMB) PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE (RELEASED 5/29/26) GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; PROVISIONS RELATED TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION (FDA) AND RELATED AGENCIES, CENTERS FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH (NIH) AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS
H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
(DRAFT) CLINICAL TRIAL MODERNIZATION ACT; ALL PROVISIONS CFF SUBMITS COMMENTS IN RESPONSE TO AN REQUEST FOR INFORMATION (RFI) FROM THE FOOD AND DRUG ADMINISTRATION (FDA) ON EXPEDITED INVESTIGATIONAL NEW DRUG PILOT PROGRAM
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS-2454-IFC GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HIGH-DEDUCTIBLE HEALTH PLANS (HDHPs) PAIRED WITH HEALTH SAVINGS ACCOUNTS (HSAs) GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS ON PHARMACY BENEFIT MANAGERS (PBMs) REFORM INCLUDING TRANSPARENCY AND ACCOUNTABILITY, SPREAD PRICING AND PRICE-LINKED COMPENSATION GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NATIONAL INSTITUTES OF HEALTH (NIH) RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL RECONCILIATION LEGISLATION CFF SUBMITS COMMENTS TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) IN RESPONSE TO THEIR REQUEST FOR INFORMATION ON THE AFFORDABLE CARE ACT'S (ACA) ESSENTIAL HEALTH BENEFITS CFF SUBMITS COMMENTS IN RESPONSE TO DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS) AND CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) REQUEST FOR INFORMATION ON HOW TO IMPLEMENT PBM MEASURES INCLUDED IN THE LAST CONSOLIDATED APPROPRIATIONS ACT CFF SUBMITS COMMENTS IN RESPONSE TO CENTERS FOR MEDICARE AND MEDICAID SERVICES (CMS) INTERIM FINAL RULE ON THE MEDICAID WORK REPORTING REQUIREMENTS
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2026 · second_quarter · Q2
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29 FOLLOW UP ON ALTERNATIVE FUNDING PROGRAMS AND IMPORTATION OF DRUGS; CFF SENDS LETTER TO FDA AND CDER REGARDING A CITIZEN PETITION CONCERNING ALTERNATIVE FUNDING PROGRAMS (AFPS) COMMENTS ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK; CFF SUBMITS COMMENTS TO THE FDA ON DRAFT GUIDANCE FOR THE PLAUSIBLE MECHANISM FRAMEWORK, URGING A FLEXIBLE APPROACH TO SUPPORT THE DEVELOPMENT OF GENE EDITING AND OTHER THERAPIES FOR PEOPLE WITH ULTRA-RARE MUTATIONS
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSION ON FY2027 APPROPRIATIONS; ISSUES RELATED TO HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, OBLIGATE STABLE PACE OF SPENDING FY26 FUNDS GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION GENERAL DISCUSSION OPPOSING OMBS PROPOSED RULE, REGULATION FOR FEDERAL FINANCIAL ASSISTANCE, RELEASED 5/29
GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK
H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6837: TO AMEND THE EMPLOYEE RETIREMENT INCOME SECURITY ACT OF 1974 TO ENSURE THAT PHARMACY BENEFIT MANAGERS ARE CONSIDERED FIDUCIARIES, AND FOR OTHER PURPOSES; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS H.R. 7895: PBM KICKBACK PROHIBITION ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 3549: PBM FIDUCIARY ACCOUNTABILITY, INTEGRITY, AND REFORM (FAIR) ACT S. 4875: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS ON NEW MEDICAID WORK REPORTING REQUIREMENTS AND DEFINITION OF MEDICAL FRAILTY DESCRIBED IN CMS IFR ON 6/1 GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HDHPS PAIRED WITH HSAS GENERAL DISCUSSION ON ALTERNATIVE FUNDING PROGRAMS (AFPS) GENERAL DISCUSSION ON DRUG PRICING REFORM GENERAL DISCUSSION ON HEALTH COVERAGE REFORM GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; ISSUES RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS PREVENTING FUTURE CUTS TO HEALTHCARE IN POTENTIAL BUDGET RECONCILIATION LEGISLATION CFF COMMENTS ON PRIOR AUTHORIZATION PROPOSED RULE; CFF SUBMITS COMMENTS FOR A PROPOSED RULE ON INTEROPERABILITY AND PRIOR AUTHORIZATION FOR DRUGS AND RELATED RFIS PPC STATEMENT IN RESPONSE TO CMS WORK REPORTING RULE; CFF JOINS PATIENT AND HEALTH GROUPS IN STATEMENT EXPRESSING CONCERN ABOUT THE CMS INTERIM FINAL RULE ON THE MEDICAID WORK CFF SENDS COMMENTS TO DOL ON PBM RULE; CFF SUBMITS COMMENTS TO DOL ON THEIR PROPOSED RULE TO IMPROVE TRANSPARENCY OF PHARMACY BENEFIT MANAGERS
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2026 · first_quarter · Q1
H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS SURROUNDING FY2027 APPROPRIATIONS; PROVISIONS RELATED TO NATIONAL INSTITUTE OF HEALTH AND FOOD AND DRUG ADMINISTRATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R 7352: PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UPSURGING RESISTANCE (PASTEUR) ACT OF 2026; ALL PROVISIONS H.R. 7879: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2026; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING NON-COMPREHENSIVE INSURANCE PRODUCTS, EXPANSION OF HEALTH DEDUCTIBLE HEALTH PLANS PAIRED WITH HEALTH SPENDING ACCOUNTS GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION
GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING RESTRICTIONS ON ADVANCE FUNDING FOR MULTI-YEAR NIH RESEARCH GRANTS; PROVISIONS RELATED TO PRESERVING THE SENATES LANGUAGE RESTRICTING ADVANCE FUNDING OF MULTI-YEAR RESEARCH GRANTS BY THE NIH GENERAL DISCUSSIONS SURROUNDING FY2027 APPROPRIATIONS; PROVISIONS RELATED TO NATIONAL INSTITUTE OF HEALTH AND FOOD AND DRUG ADMINISTRATION
GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING FY2026 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL PPC 2027 NOTICE OF BENEFIT AND PAYMENT PARAMETERS; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN COMMENTS ON 2027 HHS NOTICE OF BENEFIT AND PAYMENT PARAMETERS PPC LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES ON H.R. 1 IMPLEMENTATION; CYSTIC FIBROSIS FOUNDATION JOINS PATIENT AND HEALTH GROUPS IN LETTER TO CMS EXPRESSING CONCERNS AND ASKING FOR FURTHER CLARIFICATION ON PIECES OF H.R. 1 IMPLEMENTATION CYSTIC FIBROSIS FOUNDATION SENDS LETTER TO CENTERS FOR MEDICARE & MEDICAID SERVICES AND CENTER FOR MEDICARE AND MEDICAID INNOVATION; CYSTIC FIBROSIS FOUNDATION SUBMITS COMMENTS TO CMS/CMMI IN RESPONSE TO A PROPOSED MODEL TO ADDRESS DRUG PRICES IN MEDICARE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2025 · fourth_quarter · Q4
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT: ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 4317: PHARMACY BENEFIT MANAGER (PBM) REFORM ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS H.R. 6423: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2903: SAFE STEP ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE ENHANCED ADVANCED PREMIUM TAX CREDIT EXPIRATION AND EXTENSION GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS SURROUNDING CLARIFICATION ON THE USE AND APPLICATION OF COPAY ASSISTANCE WHEN ENROLLED IN A HDHP AND DISCUSSING HOW IT CAN BE HARMFUL TO PATIENTS TO HAVE TO CHOOSE EITHER CONTRIBUTING TO AN HSA AND NOT USE COPAY ASSISTANCE OR USE COPAY ASSISTANCE AND FORGO CONTRIBUTING TO THE HAS
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
P.L. 119-21 (H.R. 1): ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: HHS AND RELATED AGENCIES STAFFING AND FUNDING; FUNDING, STAFFING, AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2025 · third_quarter · Q3
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS H.R. 5509: SAFE STEP ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864 (& HOUSE DRAFT): HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO THE TRANSPARENCY IN COVERAGE FINAL RULE OFFERING WAYS TO IMPROVE AND ENHANCE TRANSPARENCY OF DRUG INFORMATION FOR PATIENTS AND STAKEHOLDERS
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES STAFFING AND FUNDING, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2025 · second_quarter · Q2
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2025 · first_quarter · Q1
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH (NIH) GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION STATEMENT ON ANNOUNCEMENT BY NIH THAT IT WILL SET THE REIMBURSEMENT RATE FOR INDIRECT COSTS TO 15% TO BOTH EXISTING AND NEW GRANTS COMMENTS IN RESPONSE TO DRAFT GUIDANCE ON THE USE OF MEDICAL-GRADE PULSE OXIMETERS
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2024 · fourth_quarter · Q4
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 2630: SAFE STEP ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 5378: LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8702: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS H.R. 9774: HEALTH CARE AFFORDABILITY ACT OF 2024; ALL PROVISIONS S. 652: SAFE STEP ACT; ALL PROVISIONS S. 1339: PHARMACY BENEFIT MANAGER REFORM ACT; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 3821: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 4518: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS S. 5194: HEALTH CARE AFFORDABILITY ACT OF 2024; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS REGARDING THIRD-PARTY ENTITIES THAT CONTRACT WITH EMPLOYER-SPONSORED HEALTH PLANS TO IMPORT PRESCRIPTION DRUGS FROM OUTSIDE THE UNITED STATES, ALSO KNOWN AS ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2024 · third_quarter · Q3
GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R.: 3433: GIVE KIDS A CHANCE ACT OF 2024; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024; PROVISIONS REGARDING THE REAUTHORIZATION OF THE RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS S. 4581: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2024; ALL PROVISIONS (DRAFT) CURES 2.0; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH GENERAL DISCUSSIONS REGARDING CLINICAL TRIAL DIVERSITY GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS RELATED TO ANTIMICROBIAL RESISTANCE AND THE PASTEUR ACT
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2024 · second_quarter · 2A
H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS (DRAFT) IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 1214: RARE ACT; ALL PROVISIONS S. 1355: HELP COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE ADVANCE PAYMENTS OF THE PREMIUM TAX CREDIT (APTC) UNDER THE AFFORDABLE CARE ACT AND RELATED ISSUES GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2024 · second_quarter · Q2
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 7436: ANTIMICROBIAL RESISTANCE RESEARCH ASSESSMENT ACT OF 2024; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2024 · first_quarter · Q1
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 5434: STABILIZE MEDICAID AND CHIP COVERAGE ACT; ALL PROVISIONS S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 3138: STABILIZE MEDICAID AND CHIP COVERAGE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2023 · fourth_quarter · Q4
H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2023 · third_quarter · Q3
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 3008: DRUG SHORTAGE PREVENTION ACT OF 2023; ALL PROVISIONS H.R. 3793: ENSURING ACCESS TO LIFESAVING DRUGS ACT OF 2023; ALL PROVISIONS H.R. 3810: DRUG ORIGIN TRANSPARENCY ACT OF 2023; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE (DRAFT) FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2023 · second_quarter · Q2
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE (DRAFT) FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2023 · first_quarter · Q1
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS (DRAFT) THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT; ALL PROVISIONS (DRAFT) FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT;PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES (DRAFT) PANDEMIC AND ALL HAZARDS PREPAREDNESS (PAHPA) ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2022 · fourth_quarter · Q4
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS H.R. 5566: FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT OF 2021; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS S. 3799: PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2022 · third_quarter · Q3
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4040: ADVANCING TELEHEALTH BEYOND COVID-19 ACT OF 2022; ALL PROVISIONS P.L. 117-169: (H.R. 5376) INFLATION REDUCTION ACT OF 2022; PROVISIONS RELATING TO MEDICAID COVERAGE GAP, PART D OUT OF POCKET COSTS, AND EXTENDING THE ENHANCED PREMIUM TAX CREDITS H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6833: AFFORDABLE INSULIN NOW ACT; PROVISIONS RELATING TO FDA USER FEE REAUTHORIZATION S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING ACE KIDS 2.0; ALL PROVISIONS
H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS P.L. 117-169: (H.R. 5376) INFLATION REDUCTION ACT OF 2022; PROVISIONS RELATING TO MEDICAID COVERAGE GAP, PART D OUT OF POCKET COSTS, AND EXTENDING THE ENHANCED PREMIUM TAX CREDITS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS H.R. 6833: AFFORDABLE INSULIN NOW ACT; PROVISIONS RELATING TO FDA USER FEE REAUTHORIZATION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2022 · second_quarter · Q2
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS
H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2022 · first_quarter · Q1
H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION H.R. 5376: BUILD BACK BETTER ACT (AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN); PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS
H.R. 5376: BUILD BACK BETTER ACT (AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN); PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2021 · fourth_quarter · Q4
H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISION H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2021 · third_quarter · Q3
H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS GENERAL BUDGET RECONCILIATION DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS,AND MEDICAID EXPANSION
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL BUDGET RECONCILIATION DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS,AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2021 · second_quarter · 2A
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 4100 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 1002: A BILL TO PROHIBIT FALSE OR MISLEADING ADVERTISING FOR HEALTH INSURANCE COVERAGE, REQUIRE WARNINGS AND REPORTING WITH RESPECT TO NONCOMPREHENSIVE HEALTH PLANS, ENCOURAGE ENROLLMENT IN HEALTH PLANS, AND FOR OTHER PURPOSES; ALL PROVISIONS S. 1556 (116TH CONGRESS): NO JUNK PLANS ACT; ALL PROVISIONS S. 1712 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS
H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 4100 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS S. 1712 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2021 · second_quarter · Q2
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4127: TO AMEND TITLE XVIII OF THE SOCIAL SECURITY ACT TO ENCOURAGE THE DEVELOPMENT AND USE OF DISARM ANTIMICROBIAL DRUGS, AND FOR OTHER PURPOSES; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2021 · first_quarter · Q1
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 8920 (116TH CONGRESS): THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2020; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 4100 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 1002: A BILL TO PROHIBIT FALSE OR MISLEADING ADVERTISING FOR HEALTH INSURANCE COVERAGE, REQUIRE WARNINGS AND REPORTING WITH RESPECT TO NONCOMPREHENSIVE HEALTH PLANS, ENCOURAGE ENROLLMENT IN HEALTH PLANS, AND FOR OTHER PURPOSES; ALL PROVISIONS S. 1556 (116TH CONGRESS): NO JUNK PLANS ACT; ALL PROVISIONS S. 1712 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2020 · fourth_quarter · Q4
H.R. 133: Consolidated Appropriations Act, 2021; Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions H.R. 4386: Stop the Wait Act; all provisions H.R. 4932: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 8920: The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2496: Stop the Wait Act; all provisions S. 2741: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions S. 4421: Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act; all provisions S. 4557: COVID Enrollment Response (COVER) Act; all provisions S. 4760: The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2020 · third_quarter · Q3
H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 4932: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 7269: Promising Pathway Act; all provisions H.R. 8337: Continuing Appropriations Act, 2021 and Other Extensions Act; Provisions related to funding for the National Institutes of Health (NIH), Food and Drug Administration (FDA), and related agencies S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2741: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions S. 3872: Promising Pathway Act; all provisions Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research (Draft) 21st Century Cures 2.0; all provisions of the draft (Draft) Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions of the draft (Draft) Labor, Health and Human Services (LHHS) Appropriations for Fiscal Year 2021; provisions related to funding for Health and Human Services and related agencies (Draft) Draft Agriculture Appropriations for Fiscal Year 2021; provisions related to funding for the Food and Drug Administration and related agencies
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2020 · second_quarter · Q2
H.R. 748: Coronavirus Aid, Relief, and Economic Security (CARES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 4932: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research S. 2741: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research (Draft) 21st Century Cures 2.0; all provisions of the draft (Draft) Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions of the draft (Draft) Labor, Health and Human Services (LHHS) Appropriations for Fiscal Year 2021; provisions related to funding for Health and Human Services and related agencies (Draft) Draft Agriculture Appropriations for Fiscal Year 2021; provisions related to funding for the Food and Drug Administration and related agencies
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2020 · first_quarter · Q1
H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to the Department of Health and Human Services and Health-related line items S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions (Draft) Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2021; provisions related to funding for Health and Human Services and related agencies (Draft) Draft Agriculture Appropriations for Fiscal Year 2021; provisions related to funding for the Food and Drug Administration and related agencies
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2019 · fourth_quarter · Q4
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 19: Lower Costs, More Cures Act of 2019; all provisions H.R. 1865: Further Consolidated Appropriations Act, 2020; provisions related to funding for the Health and Human Services, Food and Drug Administration, and related agencies H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019; provisions related to funding for the Food and Drug Administration and related agencies H.R. 3164: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies H.R. 4378: Continuing Appropriations Act, 2020, and Health Extenders Act of 2019; provisions related to funding for the Health and Human Services and related agencies Draft Legislation related to 21st Century Cures Act 2.0; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2522: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions (Draft) Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020; provisions related to funding for the Health and Human Services and related agencies
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2019 · third_quarter · 3A
H.R. 3: Lower Drug Costs Now Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2113: Prescription Drug STAR Act; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3 - Lower Drug Costs Now Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions The Medical Records Access Fairness Act draft; all provisions
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2019 · third_quarter · Q3
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2019 · second_quarter · Q2
H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020; provisions related to funding for the Health and Human Services and related agencies Fiscal Year 2020 Agriculture Appropriations; provisions related to funding for the Food and Drug Administration and related agencies
H.R. 2113: Prescription Drug STAR Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2019 · first_quarter · Q1
H.R. 265: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; provisions related to funding for the Food and Drug Administration and related agencies H.J.Res. 28: Further Additional Continuing Appropriations Act, 2019; provisions related to the Department of Health and Human Services and related agencies Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020; all provisions Fiscal Year 2020 Agriculture Appropriations; provisions related to funding for Food and Drug Administration and related agencies
H.R. 1226: Advancing Care for Exceptional Kids (ACE) Act of 2019; all provisions S. 317: Advancing Care for Exceptional Kids (ACE) Act of 2019; all provisions Discussion Draft: Energy and Commerce Proposals to Strengthen Pre-existing Conditions Protections and Lower Health Care Costs; all provisions Centers for Medicare and Medicaid Services: Section 1115: State Innovation Waivers; provisions regarding Virginias Waiver Application Centers for Medicare and Medicaid Services: discussions regarding work requirement proposals for very low-income parents
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2018 · fourth_quarter · Q4
H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies
H.R. 2: Agriculture Improvement Act of 2018; provisions related to Association Health Plans H.R. 7295: Medial Records Access Fairness Act; all provisions S. 3042: Agriculture Improvement Act of 2018; provisions related to Association Health Plans S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9936-NC: Provisions related to section 1332 of the Patient Protection and Affordable Care Act (PPACA) - State Relief and Empowerment Waivers
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2018 · third_quarter · Q3
H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies H. R. 6157: Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Health Resources and Services Administration, the Social Security Administration and continuing Food and Drug Administration funding S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies S. 3158: Departments of Labor, Health and Human Services, and Education and Related Agencies, Appropriations Act, 2019; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Health Resources and Services Administration, the Social Security Administration and continuing Food and Drug Administration funding
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2018 · second_quarter · 2A
H. R. 3: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2979: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions No Bill Yet Introduced: Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration No Bill Yet Introduced: Establishing the congressional budget for the United Sates Government for the fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028; Provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2018 · second_quarter · Q2
S. 2507: Improving Choices in Health Care Coverage Act; all provisions No Bill Yet Introduced: Ideas to Make Health Care Affordable Again (Senator Cassidys White Paper); all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-9924-P: Short-term, Limited-Duration Insurance; all provisions Employee Benefits Security Administration Regulation# RIN 1210-AB85: Definition of Employer Under Section 3 (5) of ERISA - Association Health Plans; all provisions
No Bill Yet Introduced: Ideas to Make Health Care Affordable Again (Senator Cassidys White Paper); all provisions of draft
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2018 · first_quarter · Q1
H. R. 195: Making Further Continuing Appropriations for the Fiscal Year Ending September 30, 2018, and For Other Purposes; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1625: Consolidated Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1892: Bipartisan Budget Act of 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2017 · fourth_quarter · Q4
No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2017; all provisions
H.R. 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction H.R. 1628: American Health Care Act of 2017/Better Care Reconciliation Act (Senate); and Graham-Cassidy-Heller-Johnson proposed amendment (S. Amdt. 1030); all provisions H.R. 3922: CHAMPIONING HEALTHY KIDS Act; all provisions H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions H.R. 4695: Bipartisan Market Stabilization and Innovation Act of 2017; all provisions S. 1: An original bill to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions S. 2052: Health Care Market Certainty and Mandate Relief Act of 2017; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2017; all provisions General discussions regarding reauthorizing the Childrens Health Insurance Program (CHIP); all provisions
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2017 · third_quarter · Q3
H.R. 1628: American Health Care Act of 2017/Better Care Reconciliation Act (Senate); and Graham-Cassidy-Heller-Johnson proposed amendment (S. Amdt. 1030); all provisions S. 1569: A bill to amend the Public Health Service Act to eliminate the non-application of certain State waiver provisions to Members of Congress and congressional staff. (Better Care Reconciliation Act); all provisions S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions General discussions regarding healthcare reform Childrens Health Insurance Program (CHIP) Reauthorization; all provisions
H.R. 878: Right to Try Act of 2017; all provisions H.R. 1628: American Health Care Act of 2017/Better Care Reconciliation Act (Senate); and Graham-Cassidy-Heller-Johnson proposed amendment (S. Amdt. 1030); all provisions H.R. 3921: HEALTHY KIDS Act; all provisions S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017; all provisions S. 1569: A bill to amend the Public Health Service Act to eliminate the non-application of certain State waiver provisions to Members of Congress and congressional staff. (Better Care Reconciliation Act); all provisions Childrens Health Insurance Program (CHIP) Reauthorization; all provisions General discussions regarding healthcare reform
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2017 · second_quarter · Q2
HR 244: Consolidated Appropriations Act, 2017; provisions related to Health and Human Services appropriations HR 1313: Preserving Employee Wellness Programs Act; provisions related to Genetic Information Nondiscrimination Act of 2008 and employee wellness programs HR 1628: American Health Care Act of 2017; all provisions H.R.5054 - (114th Congress) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration appropriations S. 2956: (114th Congress) Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration appropriations S. 3040: (114th Congress) Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health, Heath Resources and Services Administration and Centers for Disease Control and Prevention appropriations Discussions related to Better Care Reconciliation Act; all provisions Discussions related to Fiscal Year 2018 Labor, Health and Human Services, and Education Appropriations; provisions related to funding for National Institutes of Health, Health and Human Services, Health Resources and Services Administration and Centers for Disease Control and Prevention and newborn screening funding Discussions related to Fiscal Year 2018 Agriculture Appropriations; provisions related to Food and Food and Drug Administration Discussions related to Health Care Reform
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2017 · first_quarter · Q1
HR 1628: American Health Care Act of 2017: all provisions S.191: Patient Freedom Act of 2017; provisions related to preexisting conditions, benefits, Medicaid financing, subsidy structure S.222 - Obamacare Replacement Act; provisions related to preexisting conditions, benefits, Medicaid financing, subsidy structure Discussions related to health care reform as related to the rare disease community Discussions related to the National Institutes of Health and Food and Drug Administration appropriations Discussions related to Affordable Care Act reform proposals including Paul Ryans A Better Way, provisions related to high risk pools, protections for those with pre-existing conditions, Medicaid funding and Medicaid expansion Discussions related to Health Care Access issues for people with Cystic Fibrosis
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2016 · fourth_quarter · Q4
HR 34: 21st Century Cures Act; all provisions of the bill
S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Conference Report, Section 717 on military treatment facilities
Discussions regarding Budget Resolution provisions related to Potential Health Care Reform Legislation in the 115th Congress; provisions related to reconciliation instructions related to the Affordable Care Act and Medicaid
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2016 · third_quarter · Q3
HR: 6: 21st Century Cures Act; all provisions of the bill HR: 546: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 4909: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding HR: 5325: Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act; provisions related to National Institutes of Health funding and Food and Drug Administration funding HR: 5926: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 298: Advancing Care for Exceptional (ACE) Kids Act of 2015; all provisions of the bill S. 1878: Advancing Hope Act of 2016; all provisions of the bill S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2030: Advancing Targeted Therapies for Rare Diseases Act of 2016; all provisions of the bill S. 2511: Improving Health Information Technology Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to Cystic Fibrosis care exemption S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding General Discussions related to National Institutes of Health and Food and Drug Administration funding Discussions related to Prescription Drug User Fee Act VI; all provisions of the proposal
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2016 · second_quarter · Q2
HR: 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill HR: 5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; discussions related to Food and Drug Administration funding S. 185: Promised for Antibiotic and Therapeutics for Health (PATH) Act; all provisions of the bill S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill S. 2689: REGROW Act; all provisions of the bill S. 2700: FDA and NIH Workforce Authorities Modernization Act; all provisions of the bill S. 2713: Advancing Precision Medicine Act of 2016; all provisions of the bill S. 2742: Promoting Biomedical Research and Public Health for Patients Act; all provisions of the bill S. 2745: Advancing NIH Strategic Planning and Representation in Medical Research Act; all provisions of the bill S. 2943: National Defense Authorization Act for Fiscal Year 2017; provisions related to military care center access S. 2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017; provisions related to Food and Drug Administration funding S. 3040: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017; provisions related to National Institutes of Health funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2016 · first_quarter · Q1
General discussions regarding funding National Institutes of Health, Food and Drug Administration and Centers for Disease Control
S. 2014: Next Generation Researchers Act; all provisions of the bill S. 2700: Food and Drug Administration & National Institutes of Health Workforce Authorities Modernization Act; all provisions of the bill Prescription Drug User Fee Act VI; all provisions of the bill
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · fourth_quarter · Q4
HR 209/S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill HR 2029: Consolidated Appropriations Act, 2016; provisions related to Food and Drug Administration and National Institutes of Health funding HR 605/S. 275: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · third_quarter · Q3
HR 209/ S. 139: Ensuring Access to Clinical Trials Act of 2015; all provisions of the bill Bill Not Yet Introduced: Discussions related to Innovation for Healthier Americans legislation; provisions related to Food and Drug Administration & National Institutes of Health funding, laboratory developed tests, pathways for approval of drugs, clinical trial design, & biomedical research
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · second_quarter · Q2
HR 3020: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions on funding for National Institutes of Health S. 1695: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016; provisions on funding for National Institutes of Health Discussions related to Draft Agriculture/Food and Drug Administration Appropriations legislation; provisions related to funding for the Food and Drug Administration
HR 1770: Data Security and Breach Notification Act of 2015; provisions related to information security and breach notice requirements
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · first_quarter · 1A
All provisions of the Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization General discussions regarding 21st Century Cures Initiative General discussions regarding Innovation for Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2015 · first_quarter · Q1
Ensuring Access to Clinical Trials Act of 2015 (S. 139, H.R. 209) Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Funding for the Centers for Disease Control (CDC) Funding for the Health Resources and Services Administration (HRSA) Funding for the Center for Medicare and Medicaid Innovation (CMMI) General discussions regarding Childrens Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative Innovation for Healthier Americans Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · fourth_quarter · Q4
HR1281-Newborn Screening Saves Lives Reauthorization Act Reauthorization of S.1674-Improving Access to Clinical Trials Act Funding for the Food and Drug Administration (FDA) Funding for the National Institutes of Health (NIH) Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · third_quarter · Q3
Funding for the National Institutes of Health (NIH) HR1281-Newborn Screening Saves Lives Reauthorization Act HR4930-ACE Kids Act Implementation of S.1674-Improving Access to Clinical Trials Act Children's Health Insurance Program (CHIP) Reauthorization 21st Century Cures Initiative
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · second_quarter · 2A
Board on the Hill lobby day: 21st Century Cures, March on the Hill lobby day: National Institutes of Health and Food and Drug Administration funding, Teen Advocacy day: National Institutes of Health and Food and Drug Administration funding, Improving Access to Clinical Trials Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · second_quarter · 2A
Board on the Hill lobby day: 21st Century Cures, March on the Hill lobby day: National Institutes of Health and Food and Drug Administration funding, Teen Advocacy day: National Institutes of Health and Food and Drug Administration funding, Improving Access to Clinical Trials Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · second_quarter · Q2
Board on the Hill lobby day: 21st Century Cures, March on the Hill lobby day: National Institutes of Health and Food and Drug Administration funding, Teen Advocacy day: National Institutes of Health and Food and Drug Administration funding, Improving Access to Clinical Trials Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · first_quarter · Q1
March on the Hill Advocacy Day, Board on the Hill, funding and appropriations for the National Institutes of Health and Food and Drug Administration, Congressional Cystic Fibrosis Caucus, access to care measures, Affordable Care Act Implemention, Medicaid, Medicare.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2014 · first_quarter · RA
Board on the Hill lobby day, Affordable Care Act Implementation, Medicaid, Medicare, budget and appropriations, National Institutes of Health and Food and Drug Administration funding, HR 2725 the FDA SOS Act
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2013 · fourth_quarter · 4A
Board on the Hill lobby day, Affordable Care Act Implementation, Medicaid, Medicare, budget and appropriations, National Institutes of health and Food and Drug Administration funding, HR 2725 the FDA SOS Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2013 · fourth_quarter · Q4
Board on the Hill lobby day, Affordable Care Act Implementation, Medicaid, Medicare, budget and appropriations, National Institutes of health and Food and Drug Administration funding, HR 2725 the FDA SOS Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2013 · fourth_quarter · Q4
Board on the Hill lobby day, Affordable Care Act Implemention, Medicaid, Medicare, budget and appropriations, National Institutes of Health and Food and Drug Administration funding, HR 2725 the FDA SOS Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2013 · third_quarter · Q3
Funding for the National Institutes of Health and Food and Drug Administration, Social Security Disability Insurance proposed eligibility changes, Congressional Cystic Fibrosis Caucus, Hawaii Care Center advocacy, access to cystic fibrosis care under the Patient Protection and Affordable Care Act
Filing targets: Army, Dept of (Other), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2013 · second_quarter · Q2
Teen Advocacy Day, Board on the Hill, funding for the National Institutes of Health and Food and Drug Administration, Social Security Disability Insurance proposed eligibility changes, Congressional Cystic Fibrosis Caucus, Hawaii Care Center advocacy, health reform access to care measures
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2013 · first_quarter · Q1
Board on the Hill and March on the Hill advocacy days, Sequestration, NIH-FDA Budget, FDA Breakthrough Designation, Prescription Drug User Fee Act Congressional follow up, International CF project, Lasker award congressional support, federal budget and appropriations, Social Security Disability Insurance eligibility changes, Medicaid cost-sharing
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2012 · fourth_quarter · Q4
American Thoracic Society briefing, FDA, NIH, Sequestration, Fiscal Cliff and Budget, Hawaii Care Center access for civilians, Rare Disease Legislative Advocates briefing, international patient visa issue, Board on the Hill event, ACA comments (Essential Health Benefits, Medicaid Expansion, Insurance Exchanges), CMS Comments
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2012 · third_quarter · Q3
FDA (EXPERRT, PDUFA) follow up, Board on the Hill, Appropriations and Sequestration (NIH & FDA), Teen Advocacy Day follow up, Congressional CF Caucus, Congressional Briefings, Make Every Breath Count grassroots campaign, 340B, Meeting with White House Science and Technology office, communications to grassroots advocates, Essential Health Benefits & Exchanges under PPACA, coverage for Kalydeco, Medicaid drug coverage
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2012 · second_quarter · Q2
House, Senate, FDA, Energy and Commerce and Labor-HHS Committee on Prescription Drug User Fee Act Agreement (PDUFA V), HR 4156, and S 2218; funding for National Center for Advancing Translational Sciences (NCATS) at NIH, FDA funding, NIH funding; FY13 Appropriations and Sequestration; CMS/Medicaid; Congressional CF Caucus; Patient Protection and Affordable Care Act and general health reform issues; Teen Advocacy Day and May Board on the Hill lobby days
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2012 · first_quarter · Q1
House, Senate, FDA on EXPERRT Act (HR 4156, S 2218), Energy and Commerce and Labor-HHS Committee on Prescription Drug User Fee Act Agreement (PDUFA V), funding for National Center for Advancing Translational Sciences (NCATS) at NIH, FDA funding, NIH funding, Appropriations testimony, FTC on MedCo ExpressScripts merger, CMS on Medicare and Medicaid, Congressional CF Caucus, HHS comments on health reform and other regulations, FDA on Kalydeco
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2011 · fourth_quarter · Q4
Medicaid, Medicare, Deficit Reduction Committee-re: protecting Medicaid from budget cuts, PDUFA, FTC on Medco Express Scripts merger, review of FDA reform and messaging, NIH and FDA funding, NCATS establishment at NIH, TREAT Act, Health Care Reform implementation, strategic planning for grassroots agenda
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2011 · third_quarter · Q3
NIH, FDA, L-HHS Appropriations; NCATS establishment and funding; CMS, SSA and Congress on Medicare and Medicaid funding and coverage decisions; CF Caucus support; Energy and Commerce Committee on PDUFA and general strategies; HHS comments and statements on health reform and other regulations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2011 · third_quarter · RA
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2011 · second_quarter · 2A
NIH, FDA, L-HHS Appropriations, FDA Appropriations, PDUFA & general strategies, CMS coverage decisions OIG (Pari nebulizer) & HCPCS coding for Hypertonic Saline, Medicaid and Medicare, SSA- Improving Access to Clinical Trials Act, SBIR, Health care reform implementation ACO comments, CF Caucus
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2011 · second_quarter · Q2
NIH, FDA, L-HHS Appropriations, FDA Appropriations, PDUFA & general strategies, CMS coverage decisions OIG (Pari nebulizer) & HCPCS coding for Hypertonic Saline, Medicaid and Medicare, SSA- Improving Access to Clinical Trials Act, SBIR, Health care reform implementation ACO comments, CF Caucus
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2011 · first_quarter · Q1
FDA & NIH appropriations, NIH - NCATS, CMS - coverage for CF drugs & health reform implementation, SSA Improving Access to Clinical Trials Act implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · fourth_quarter · 4A
Healthcare reform; NIH & FDA appropriations; FDA reauthorization; CMS - device & home IV coverage; FDA- Prescription Drug User Fee Act, 340B Drug Pricing Program; Social Security Administration re: "Improving Access to Clinical Trials Act" implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · second_quarter · 2A
Appropriations for FDA and NIH; HR 2866 the Improving Access to Clinical Trials Act of 2009; GAO Nominations to the Patient-Centered Outcomes Research Institute; SSA compassionate allowance; CMS - Home Infusion; HR 4926 Medical Foods Act;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · fourth_quarter · Q4
Healthcare reform; NIH & FDA appropriations; FDA reauthorization; CMS - device & home IV coverage; FDA- Prescription Drug User Fee Act, 340B Drug Pricing Program; Social Security Administration re: "Improving Access to Clinical Trials Act" implementation
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · third_quarter · Q3
Clinical research S. 1675 "Improving Access to Clinical Trials Act" passage & implementation; Health care reform & implementation including B. Marshalls PCORI nomination, comment submissions; FDA funding & processes; NIH funding & processes; CMS coverage decisions including: home IV & DME; 340B Drug Pricing Program; FDA drug approval process
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · second_quarter · Q2
Appropriations for FDA and NIH; HR 2866 the Improving Access to Clinical Trials Act of 2009; GAO Nominations to the Patient-Centered Outcomes Research Institute; SSA compassionate allowance; CMS - Home Infusion; HR 4926 Medical Foods Act;
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · second_quarter · RA
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · first_quarter · 1A
Appropriations Funding for NIH, FDA, AHRQ; support for HR 2866, the Improving Access to Clinical Trials Act; health reform; HR 2965, Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; Home Infusion Guidance from CMS
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · first_quarter · Q1
Appropriations funding for NIH, FDA, AHRQ; support for HR 2866 the Improving Access to Clinical Trials Act of 2009; health reform; HR 2965 Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; home infusion guidance with CMS.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · fourth_quarter · 4A
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · fourth_quarter · Q4
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · third_quarter · Q3
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · first_quarter · 1A
stimulus package, Children's Health Insurance Program, increase in fudnign for NIH, health care research & quality, pharmacy waivers from CMS, FDA's denial of Gilead Sciences Aztreonam Lysine, Social Security Income rules, Small Business Innovation & Research program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · third_quarter · Q3
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · second_quarter · Q2
Increased funding for NIH; Support for H.R. 2866, the Improving Access to Clinical Trials Act of 2009; Health Reform; H.R. 2965 Reauthorizing the Small Business Innovation and Research Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · first_quarter · Q1
stimulus package, Children's Health Insurance Program, increase in fudnign for NIH, health care research & quality, pharmacy waivers from CMS, FDA's denial of Gilead Sciences Aztreonam Lysine, Social Security Income rules, Small Business Innovation & Research program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · first_quarter · Q1
Stimulus package, Children's Health Insurance Program, increase in funding for National Institutes of Health, health care research & quality, pharmacy waivers from CMS, FDA's denial of Gilead Sciences Aztreonam Lysine, Social Security Income rules, Small Business Innovation & Research program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · fourth_quarter · Q4
The CF Foundation includes the following in its 2008 lobbying activities: calling on Congress and the Executive branch to improve access to specialized care and a reduction in the high cost of medicine for CF patients, requests to increase public investment for drug and disease research particularly for the National Institutes of Health, requests for the Food & Drug Administration to reconsider the drug application Gilead Sciences submitted for Aztreonam Lysine for Inhalation (AZLI), requests to Congress to reauthorize the Small Business Innovation Research (SBIR) program, and requests to the Social Security Administration to change Social Security Income requirements.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · third_quarter · Q3
Social Security Income, Access to care issues, NIH funding
Small Business Research Innovation Research program
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · second_quarter · Q2
Access to health care, NIH funding, Social Security Administration's eligibility rules impact on clinical trials, Labor HHS appropriations, Small Business Innovation Research, H.Con.Res.299 - Cystic Fibrosis Awareness Resolution, S.Res.510 - Cystic Fibrosis Awareness Resolution
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · first_quarter · Q1
Small Business Innovation Research program, NIH, Newborn Screening, clinical trials funding, Social Security - Compassionate Allowance
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · year_end · YA
SCHIP, Follow-on biologics, small business research grants, NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · mid_year · MA
Newborn Screening, FDA reauthorization, SCHIP reauthorization, Follow-on biologics, Home Infusion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · year_end · YA
SCHIP, follow-on biologics, small business research grants, NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · year_end · YY
SCHIP, follow-on biologics, small business research grants, NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · mid_year · MM
Newborn Screening, FDA reauthorization, SCHIP reauthorization, Follow-on biologics, Home Infusion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING THE USE AND PRACTICES OF ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL COMMENTS IN RESPONSE TO DRAFT RULE ON PATIENT PROTECTION AND AFFORDABLE CARE ACT; MARKETPLACE INTEGRITY AND AFFORDABILITY PROPOSED RULE LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
H.R. 1: ONE BIG BEAUTIFUL BILL ACT: PROVISIONS RELATED TO ACA MARKETPLACE CHANGES, MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, AND FUNDING FOR NUTRITION ASSISTANCE PROGRAMS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2902: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 1406: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2025; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
H.R. 142: REGULATIONS FROM THE EXECUTIVE IN NEED OF SCRUTINY (REINS) ACT OF 2025; ALL PROVISIONS S. RES. 198: A RESOLUTION EXPRESSING THE SENSE OF THE SENATE THE SECRETARY OF HEALTH AND HUMAN SERVICES SHOULD WITHDRAW A REDUCTION IN PUBLIC NOTICE AND COMMENT OPPORTUNITIES; ALL PROVISIONS LETTER TO ADMINISTRATION ON LARGE-SCALE AND RAPID REDUCTIONS IN WORKFORCE, URGING THE ADMINISTRATION TO REVERSE THEM
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Social Security Administration (SSA)
H.R. 247: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS H.R. 2079: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS S. 46: HEALTH CARE AFFORDABILITY ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 864: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 976: INSURANCE FRAUD ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) MODERNIZING AND ENSURING PBM ACCOUNTABILITY (MEPA) ACT; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS (DRAFT) SAFE STEP ACT; ALL PROVISIONS (DRAFT) LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS SURROUNDING THE EXTENSION OF THE AFFORDABLE CARE ACTS ENHANCED ADVANCED PREMIUM TAX CREDITS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING MAINTAINING LIMITS ON SHORT-TERM LIMITED DURATION INSURANCE PLANS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 1262: GIVE KIDS A CHANCE ACT OF 2025; ALL PROVISIONS (DRAFT) PASTEUR ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING ANTIBIOTICS REIMBURSEMENT AND INCENTIVIZING THE DEVELOPMENT OF NOVEL ANTIMICROBIALS GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL STATEMENT ON ANNOUNCEMENT BY NIH THAT IT WILL SET THE REIMBURSEMENT RATE FOR INDIRECT COSTS TO 15% TO BOTH EXISTING AND NEW GRANTS COMMENTS IN RESPONSE TO DRAFT GUIDANCE ON THE USE OF MEDICAL-GRADE PULSE OXIMETERS GENERAL DISCUSSIONS SURROUNDING PROPOSED FRAMEWORK FOR REFORMING THE NATIONAL INSTITUTES OF HEALTH (NIH)
H.R. 1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S. 752: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS (DRAFT) THE SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT; ALL PROVISIONS GENERAL DISCUSSIONS SURROUNDING THE EXPANSION OF TELEHEALTH SERVICES FOR PATIENTS GENERAL DISCUSSIONS SURROUNDING MAINTAINING ACCESS TO MEDICAID AND PROPOSED CHANGES TO THE PROGRAM GENERAL DISCUSSIONS SURROUNDING: FUNDING AND SUPPORT FOR THE NIH AND FDA; MAINTAINING ACCESS TO MEDICAID; THE EXTENSION OF THE ACAS ENHANCED ADVANCED PREMIUM TAX CREDITS; LIMITING SHORT-TERM LIMITED DURATION PLANS; PBM REFORM THAT IS PATIENT CENTERED; ANTIMICROBIAL INVESTMENT AND PAYMENT MODELS; TELEHEALTH SERVICES GENERAL DISCUSSIONS SURROUNDING FY2025 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS. HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, NIH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION. POLICY RIDERS INCLUDED IN A DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 77: MIDNIGHT RULES RELIEF ACT; ALL PROVISIONS H.R. 142: REGULATIONS FROM THE EXECUTIVE IN NEED OF SCRUTINY (REINS) ACT OF 2025; ALL PROVISIONS H.R. 1515: GUIDANCE OUT OF DARKNESS (GOOD) ACT; ALL PROVISIONS S. 164: MIDNIGHT RULES RELIEF ACT OF 2025; ALL PROVISIONS S. 252: GUIDANCE OUT OF DARKNESS (GOOD) ACT; ALL PROVISIONS STATEMENT ON POLICY CHANGE BY HHS THAT REQUIRED THE DEPARTMENT TO CONDUCT PUBLIC NOTICE AND COMMENT PROCEDURES ON A WIDE RANGE OF POLICY ACTION
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, White House Office
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2630: SAFE STEP ACT; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R.: 3433: GIVE KIDS A CHANCE ACT OF 2024; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 5378: LOWER COSTS, MORE TRANSPARENCY ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024; PROVISIONS REGARDING THE REAUTHORIZATION OF THE RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8702: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS H.R. 8964: MEDICAL RECORDS ACCESS FAIRNESS ACT OF 2024; ALL PROVISION H.R. 9774: HEALTH CARE AFFORDABILITY ACT OF 2024; ALL PROVISIONS S. 652: SAFE STEP ACT; ALL PROVISIONS S. 1339: PHARMACY BENEFIT MANAGER REFORM ACT; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 3821: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS S. 4518: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS S. 4581: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2024; ALL PROVISIONS S. 5194: HEALTH CARE AFFORDABILITY ACT OF 2024; ALL PROVISIONS (DRAFT) CURES 2.0; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS REGARDING PROPOSED FRAMEWORK FOR REFORMING NATIONAL INSTITUTES OF HEALTH GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS REGARDING THIRD-PARTY ENTITIES THAT CONTRACT WITH EMPLOYER-SPONSORED HEALTH PLANS TO IMPORT PRESCRIPTION DRUGS FROM OUTSIDE THE UNITED STATES, ALSO KNOWN AS ALTERNATIVE FUNDING PLANS
H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8702: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 3821: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 4518: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R.: 3433: GIVE KIDS A CHANCE ACT OF 2024; ALL PROVISIONS H.R. 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024; PROVISIONS REGARDING THE REAUTHORIZATION OF THE RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS S. 4581: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2024; ALL PROVISIONS (DRAFT) CURES 2.0; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING PROPOSED FRAMEWORK FOR REFORMING NATIONAL INSTITUTES OF HEALTH GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8702: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 3821: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 4518: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 1692: HEALTH CARE AFFORDABILITY ACT OF 2023: ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R.: 3433: GIVE KIDS A CHANCE ACT OF 2024; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7384: CREATING HOPE REAUTHORIZATION ACT OF 2024; PROVISIONS REGARDING THE REAUTHORIZATION OF THE RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8702: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS H.R. 8694: MEDICAL RECORDS ACCESS FAIRNESS ACT OF 2024; ALL PROVISION H.R. 9774: HEALTH CARE AFFORDABILITY ACT OF 2024; ALL PROVISIONS S. 8: IMPROVING HEALTH INSURANCE AFFORDABILITY ACT OF 2023; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 3821: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS S. 4518: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS S. 4581: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2024; ALL PROVISIONS (DRAFT) CURES 2.0; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS REGARDING PROPOSED FRAMEWORK FOR REFORMING NATIONAL INSTITUTES OF HEALTH GENERAL DISCUSSIONS REGARDING DRAFT BILL ON TAX CREDITS FOR AMR DEVELOPMENT GENERAL DISCUSSIONS REGARDING CLINICAL TRIAL DIVERSITY GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS REGARDING THE CONSUMER FINANCIAL PROTECTION BUREAU'S PURPOSED RULE TO PROHIBIT THE USE OF MEDICAL INFORMATION BY CREDITORS FOR CREDIT DETERMINATIONS GENERAL DISCUSSIONS REGARDING THIRD-PARTY ENTITIES THAT CONTRACT WITH EMPLOYER-SPONSORED HEALTH PLANS TO IMPORT PRESCRIPTION DRUGS FROM OUTSIDE THE UNITED STATES, ALSO KNOWN AS ALTERNATIVE FUNDING PLANS GENERAL DISCUSSIONS RELATED TO ANTIMICROBIAL RESISTANCE AND THE PASTEUR ACT
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1692: HEALTH CARE AFFORDABILITY ACT OF 2023: ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8702: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS H.R. 9774: HEALTH CARE AFFORDABILITY ACT OF 2024; ALL PROVISIONS S. 8: IMPROVING HEALTH INSURANCE AFFORDABILITY ACT OF 2023; ALL PROVISIONS S. 1355: HELP COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 3821: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 4518: IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT OF 2024; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING PHARMACY BENEFIT MANAGER PRACTICES GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, NATIONAL INSTITUTES OF HEALTH AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION; AND POLICY RIDERS IN DRAFT LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION RELATED AGENCIES FUNDING BILL GENERAL DISCUSSIONS REGARDING THIRD-PARTY ENTITIES THAT CONTRACT WITH EMPLOYER-SPONSORED HEALTH PLANS TO IMPORT PRESCRIPTION DRUGS FROM OUTSIDE THE UNITED STATES, ALSO KNOWN AS ALTERNATIVE FUNDING PLANS
Filing targets: Consumer Financial Protection Bureau (CFPB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, White House Office
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 7436: ANTIMICROBIAL RESISTANCE RESEARCH ASSESSMENT ACT OF 2024; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7436: ANTIMICROBIAL RESISTANCE RESEARCH ASSESSMENT ACT OF 2024; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8467: FARM, FOOD, AND NATIONAL SECURITY ACT OF 2024; PROVISIONS RELATING TO SUPPLEMENTAL NUTRITION ASSISTANCE PROGRAM (SNAP) AND THE THRIFTY FOOD PLAN S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS (DRAFT) IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT; ALL PROVISIONS (DRAFT) MEDICAL RECORDS ACCESS FAIRNESS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE ADVANCE PAYMENTS OF THE PREMIUM TAX CREDIT (APTC) UNDER THE AFFORDABLE CARE ACT AND RELATED ISSUES GENERAL DISCUSSIONS REGARDING DRAFT BILL ON TAX CREDITS FOR AMR DEVELOPMENT GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7436: ANTIMICROBIAL RESISTANCE RESEARCH ASSESSMENT ACT OF 2024; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS H.R. 8467: FARM, FOOD, AND NATIONAL SECURITY ACT OF 2024; PROVISIONS RELATING TO SUPPLEMENTAL NUTRITION ASSISTANCE PROGRAM (SNAP) AND THE THRIFTY FOOD PLAN S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 4426: PROMISING PATHWAY ACT 2.0; ALL PROVISIONS (DRAFT) IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT; ALL PROVISIONS (DRAFT) MEDICAL RECORDS ACCESS FAIRNESS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE ADVANCE PAYMENTS OF THE PREMIUM TAX CREDIT (APTC) UNDER THE AFFORDABLE CARE ACT AND RELATED ISSUES GENERAL DISCUSSIONS REGARDING DRAFT BILL ON TAX CREDITS FOR AMR DEVELOPMENT GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS (DRAFT) IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 7383: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT; ALL PROVISIONS H.R. 7623: TELEHEALTH MODERNIZATION ACT OF 2024; ALL PROVISIONS H.R. 7829: SUPPLEMENTAL OXYGEN ACCESS REFORM (SOAR) ACT OF 2024; ALL PROVISIONS S. 1214: RARE ACT; ALL PROVISIONS S. 1355: HELP COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE ADVANCE PAYMENTS OF THE PREMIUM TAX CREDIT (APTC) UNDER THE AFFORDABLE CARE ACT AND RELATED ISSUES GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, PUBLIC HEALTH WORKFORCE REPAYMENT PROGRAM, BIO-PREPAREDNESS WORKFORCE PILOT PROGRAM AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 7436: ANTIMICROBIAL RESISTANCE RESEARCH ASSESSMENT ACT OF 2024; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 5434: STABILIZE MEDICAID AND CHIP COVERAGE ACT; ALL PROVISIONS H.R. 7436: ANTIMICROBIAL RESISTANCE RESEARCH ASSESSMENT ACT OF 2024; ALL PROVISIONS S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS S. 3138: STABILIZE MEDICAID AND CHIP COVERAGE ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS H.R. 5434: STABILIZE MEDICAID AND CHIP COVERAGE ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 3138: STABILIZE MEDICAID AND CHIP COVERAGE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE 2025 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 4408: PROMISING PATHWAY ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 1906: PROMISING PATHWAY ACT; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION DISCUSSIONS REGARDING IMPLEMENTATION OF SECTION 1860D-2 OF THE SOCIAL SECURITY ACT OF 2025-MEDICARE PRESCRIPTION PAYMENT PLAN
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 3008: DRUG SHORTAGE PREVENTION ACT OF 2023; ALL PROVISIONS H.R. 3793: ENSURING ACCESS TO LIFESAVING DRUGS ACT OF 2023; ALL PROVISIONS H.R. 3810: DRUG ORIGIN TRANSPARENCY ACT OF 2023; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS (DRAFT) FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION DISCUSSIONS REGARDING IMPLEMENTATION OF SECTION 1860D-2 OF THE SOCIAL SECURITY ACT OF 2025-MEDICARE PRESCRIPTION PAYMENT PLAN LETTER TO FOOD AND DRUG ADMINISTRATION CENTER FOR BIOLOGICS EVALUATION AND RESEARCH TO DISCUSS CLINICAL TRIAL DESIGN FOR CYSTIC FIBROSIS THERAPIES; ISSUES RELATED TO NOVEL APPROACHES TO CLINICAL TRIAL DESIGN FOR CYSTIC FIBROSIS NUCLEIC ACID-BASED THERAPIES
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 4758: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 1214: RETAINING ACCESS AND RESTORING EXCLUSIVITY (RARE) ACT: ALL PROVISIONS S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 2372: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S. 2973: MODERNIZING AND ENSURING PBM ACCOUNTABILITY ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION DISCUSSIONS REGARDING IMPLEMENTATION OF SECTION 1860D-2 OF THE SOCIAL SECURITY ACT OF 2025-MEDICARE PRESCRIPTION PAYMENT PLAN
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 3746: FISCAL RESPONSIBILITY ACT OF 2023; PROVISIONS RELATING TO HEALTH CARE COVERAGE AND ACCESS, AND H.R. 277 (REINS ACT OF 2023) S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 824: TELEHEALTH BENEFIT EXPANSION FOR WORKERS ACT OF 2023; ALL PROVISIONS H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS H.R. 2940: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS H.R. 3746: FISCAL RESPONSIBILITY ACT OF 2023; PROVISIONS RELATING TO HEALTH CARE COVERAGE AND ACCESS, AND H.R. 277 (REINS ACT OF 2023) S. 1269: IMPROVING NEEDED SAFEGUARDS FOR USERS OF LIFESAVING INSULIN NOW (INSULIN) ACT OF 2023; ALL PROVISIONS S. 1355: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2023; ALL PROVISIONS S. 1375: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 2333: PANDEMIC AND ALL HAZARDS PREPAREDNESS AND RESPONSE ACT; PROVISIONS RELATING TO PUBLIC HEALTH EMERGENCY PREPAREDNESS AND COMBATING ANTIMICROBIAL RESISTANCE (DRAFT) FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1305: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2023; ALL PROVISIONS (DRAFT) THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT; ALL PROVISIONS (DRAFT) FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT; ALL PROVISIONS (DRAFT) PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT;PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES (DRAFT) PANDEMIC AND ALL HAZARDS PREPAREDNESS (PAHPA) ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 830: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2024 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR DOMESTIC AND GLOBAL AMR PROGRAMS, AND PROTECTION OF MEDICARE, MEDICAID, AND SOCIAL SECURITY PROGRAMS, HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4040: ADVANCING TELEHEALTH BEYOND COVID-19 ACT OF 2022; ALL PROVISIONS H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING ACE KIDS 2.0; ALL PROVISIONS
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS H.R. 4040: ADVANCING TELEHEALTH BEYOND COVID-19 ACT OF 2022; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS H.R. 5566: FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT OF 2021; ALL PROVISIONS H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS H.R. 9303: SAVING US FROM PANDEMIC ERA RESISTANCE BY BUILDING A UNIFIED GLOBAL STRATEGY (SUPER BUGS) ACT OF 2022; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS S. 3799: PREPARE FOR AND RESPOND TO EXISTING VIRUSES, EMERGING NEW THREATS, AND (PREVENT) PANDEMICS ACT; PROVISIONS REGARDING MEDICAL SUPPLY CHAIN, HEALTH DISPARITIES, PUBLIC HEALTH PREPAREDNESS AND RESPONSE CAPABILITIES GENERAL DISCUSSIONS REGARDING ACE KIDS 2.0; ALL PROVISIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION H.R. 4040: ADVANCING TELEHEALTH BEYOND COVID-19 ACT OF 2022; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS P.L. 117-169: (H.R. 5376) INFLATION REDUCTION ACT OF 2022; PROVISIONS RELATING TO MEDICAID COVERAGE GAP, PART D OUT OF POCKET COSTS, AND EXTENDING THE ENHANCED PREMIUM TAX CREDITS H.R. 5566: FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT OF 2021; ALL PROVISIONS H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS H.R. 6833: AFFORDABLE INSULIN NOW ACT; PROVISIONS RELATING TO FDA USER FEE REAUTHORIZATION S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING ACE KIDS 2.0; ALL PROVISIONS
P.L. 117-169: (H.R. 5376) INFLATION REDUCTION ACT OF 2022; PROVISIONS RELATING TO MEDICAID COVERAGE GAP, PART D OUT OF POCKET COSTS, AND EXTENDING THE ENHANCED PREMIUM TAX CREDITS H.R. 6833: AFFORDABLE INSULIN NOW ACT; PROVISIONS RELATING TO FDA USER FEE REAUTHORIZATION
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS P.L. 117-169: (H.R. 5376) INFLATION REDUCTION ACT OF 2022; PROVISIONS RELATING TO MEDICAID COVERAGE GAP, PART D OUT OF POCKET COSTS, AND EXTENDING THE ENHANCED PREMIUM TAX CREDITS H.R. 5566: FINDING ORPHAN-DISEASE REMEDIES WITH ANTIFUNGAL RESEARCH AND DEVELOPMENT (FORWARD) ACT OF 2021; ALL PROVISIONS H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS H.R. 6833: AFFORDABLE INSULIN NOW ACT; PROVISIONS RELATING TO FDA USER FEE REAUTHORIZATION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE 2023 FISCAL YEAR APPROPRIATIONS; PROVISIONS RELATING TO FUNDING FOR HHS AND RELATED AGENCIES, FDA AND RELATED AGENCIES, CDC AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 6000: CURES 2.0 ACT; ALL PROVISIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 5376: BUILD BACK BETTER ACT (AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN); PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION
H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION H.R. 5376: BUILD BACK BETTER ACT (AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN); PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION
H.R. 5376: BUILD BACK BETTER ACT (AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN); PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS GENERAL BUDGET RECONCILIATION DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS,AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 3932: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS H.R. 5030: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS H.R. 5376: BUILD BACK BETTER ACT; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION H.R. 5801: HELP ENSURE LOWER PATIENT (HELP) COPAYS ACT; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS S. 2706: DIVERSIFYING INVESTIGATIONS VIA EQUITABLE RESEARCH STUDIES FOR EVERYONE (DIVERSE) TRIALS ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL BUDGET RECONCILIATION DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS,AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISIONS GENERAL BUDGET RECONCILIATION DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY, AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4127: DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL MICROORGANISMS (DISARM) ACT OF 2021; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS GENERAL BUDGET RECONCILIATION DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS,AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 4100 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS H.R. 8920 (116TH CONGRESS): THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2020; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 1002: A BILL TO PROHIBIT FALSE OR MISLEADING ADVERTISING FOR HEALTH INSURANCE COVERAGE, REQUIRE WARNINGS AND REPORTING WITH RESPECT TO NONCOMPREHENSIVE HEALTH PLANS, ENCOURAGE ENROLLMENT IN HEALTH PLANS, AND FOR OTHER PURPOSES; ALL PROVISIONS S. 1556 (116TH CONGRESS): NO JUNK PLANS ACT; ALL PROVISIONS S. 1712 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 8920 (116TH CONGRESS): THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2020; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 4127: TO AMEND TITLE XVIII OF THE SOCIAL SECURITY ACT TO ENCOURAGE THE DEVELOPMENT AND USE OF DISARM ANTIMICROBIAL DRUGS, AND FOR OTHER PURPOSES; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 942: NO JUNK PLANS ACT; ALL PROVISIONS S. 1002: JUNK PLAN ACCOUNTABILITY AND DISCLOSURE ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE ACE KIDS 2.0 ACT; ALL PROVISIONS OF THE DRAFT
H.R. 4127: TO AMEND TITLE XVIII OF THE SOCIAL SECURITY ACT TO ENCOURAGE THE DEVELOPMENT AND USE OF DISARM ANTIMICROBIAL DRUGS, AND FOR OTHER PURPOSES; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION
H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 869: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 289: RESEARCH INVESTMENT TO SPARK THE ECONOMY (RISE) ACT OF 2021; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 2076: THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2021; ALL PROVISION GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR DEPARTMENT OF HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, AND CENTER FOR DISEASE CONTROL AND PREVENTION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION GENERAL DISCUSSIONS REGARDING THE AMERICAN FAMILIES PLAN & AMERICAN JOBS PLAN; PROVISIONS RELATED TO PAID FAMILY AND MEDICAL LEAVE, INDIVIDUAL MARKET PREMIUM SUBSIDIES, AFFORDABLE CARE ACT PROVISIONS, AND MEDICAID EXPANSION GENERAL DISCUSSIONS REGARDING THE CURES 2.0 ACT; ALL PROVISIONS OF THE DRAFT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 482: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS H.R. 708: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 4100 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS H.R. 8920 (116TH CONGRESS): THE PIONEERING ANTIMICROBIAL SUBSCRIPTIONS TO END UP SURGING RESISTANCE (PASTEUR) ACT OF 2020; ALL PROVISIONS S. 168: TEMPORARY RECIPROCITY TO ENSURE ACCESS TO TREATMENT (TREAT) ACT; ALL PROVISIONS S. 350: NEWBORN SCREENING SAVES LIVES REAUTHORIZATION ACT OF 2021; ALL PROVISIONS S. 368: TELEHEALTH MODERNIZATION ACT; ALL PROVISIONS S. 1002: A BILL TO PROHIBIT FALSE OR MISLEADING ADVERTISING FOR HEALTH INSURANCE COVERAGE, REQUIRE WARNINGS AND REPORTING WITH RESPECT TO NONCOMPREHENSIVE HEALTH PLANS, ENCOURAGE ENROLLMENT IN HEALTH PLANS, AND FOR OTHER PURPOSES; ALL PROVISIONS S. 1556 (116TH CONGRESS): NO JUNK PLANS ACT; ALL PROVISIONS S. 1712 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS
H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH GENERAL DISCUSSIONS REGARDING FISCAL YEAR 2022 APPROPRIATIONS; PROVISIONS RELATED TO FUNDING FOR HEALTH AND HUMAN SERVICES AND RELATED AGENCIES, FOOD AND DRUG ADMINISTRATION AND RELATED AGENCIES, FUNDING FOR NUTRITION ASSISTANCE PROGRAMS, AND MEDICAL EXPENSE DEDUCTION
H.R. 1319: AMERICAN RESCUE PLAN ACT OF 2021; PROVISIONS RELATED PAID FAMILY AND MEDICAL LEAVE, PERSONAL PROTECTIVE EQUIPMENT, AND ACCESS TO MEDICINE, NUTRITION ASSISTANCE PROGRAMS, AND ANTIMICROBIAL RESEARCH H.R. 4100 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS S. 1712 (116TH CONGRESS): DEVELOPING AN INNOVATIVE STRATEGY FOR ANTIMICROBIAL RESISTANT MICROORGANISMS (DISARM) ACT OF 2019; ALL PROVISIONS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions H.R. 4386: Stop the Wait Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 2496: Stop the Wait Act; all provisions S. 4421: Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act; all provisions S. 4557: COVID Enrollment Response (COVER) Act; all provisions
H.J. Res. 110: Extension of Continuing Appropriations Act, 2021; provisions related to funding for Health and Human Services and related agencies, Food and Drug Administration and related agencies, funding for nutrition assistance programs, and medical expense deduction H.R. 133: Consolidated Appropriations Act, 2021; Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research, funding for Department of Health and Human Services (HHS) and related agencies, Food and Drug Administration (FDA) and related agencies H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 4932: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 8920: The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2741: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions S. 4760: The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions
H.R. 133: Consolidated Appropriations Act, 2021; Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research
H.J. Res. 110: Extension of Continuing Appropriations Act, 2021; provisions related to funding for the Department of Health and Human Services (HHS) and related agencies, Food and Drug Administration (FDA) and related agencies, funding for nutrition assistance programs, and medical expense deduction H.R. 133: Consolidated Appropriations Act, 2021; Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, access to medicine, nutrition assistance programs, antimicrobial research, funding for Department of Health and Human Services (HHS) and related agencies, Food and Drug Administration (FDA) and related agencies H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research
H.R. 133: Consolidated Appropriations Act, 2021; Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions H.R. 4386: Stop the Wait Act; all provisions H.R. 4932: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 7269: Promising Pathway Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2496: Stop the Wait Act; all provisions S. 2741: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions S. 3872: Promising Pathway Act; all provisions S. 4421: Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act; all provisions S. 4557: COVID Enrollment Response (COVER) Act; all provisions Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research (Draft) 21st Century Cures 2.0; all provisions of the draft (Draft) Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions of the draft
H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research
H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions H.R. 4386: Stop the Wait Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 2496: Stop the Wait Act; all provisions S. 4421: Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act; all provisions S. 4557: COVID Enrollment Response (COVER) Act; all provisions
H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research
H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 8337: Continuing Appropriations Act, 2021 and Other Extensions Act; Provisions related to funding for the National Institutes of Health (NIH), Food and Drug Administration (FDA), and related agencies Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research (Draft) Labor, Health and Human Services (LHHS) Appropriations for Fiscal Year 2021; provisions related to funding for Health and Human Services and related agencies (Draft) Draft Agriculture Appropriations for Fiscal Year 2021; provisions related to funding for the Food and Drug Administration and related agencies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 748: Coronavirus Aid, Relief, and Economic Security (CARES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research
H.R. 748: Coronavirus Aid, Relief, and Economic Security (CARES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research (Draft) Labor, Health and Human Services (LHHS) Appropriations for Fiscal Year 2021; provisions related to funding for Health and Human Services and related agencies (Draft) Draft Agriculture Appropriations for Fiscal Year 2021; provisions related to funding for the Food and Drug Administration and related agencies
H.R. 748: Coronavirus Aid, Relief, and Economic Security (CARES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; Provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research
H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
H.R. 748: Coronavirus Aid, Relief, and Economic Security (CARES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions H.R. 4932: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research H.R. 6800: Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 2741: Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019; all provisions Discussions surrounding additional coronavirus relief measures; provisions related to paid family and medical leave, personal protective equipment, and access to medicine, nutrition assistance programs, and antimicrobial research (Draft) 21st Century Cures 2.0; all provisions of the draft (Draft) Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act of 2020; all provisions of the draft
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to the Department of Health and Human Services and Health-related line items (Draft) Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2021; provisions related to funding for Health and Human Services and related agencies (Draft) Draft Agriculture Appropriations for Fiscal Year 2021; provisions related to funding for the Food and Drug Administration and related agencies
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to the Department of Health and Human Services and Health-related line items Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions H.R. 6074: Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; provisions related to the Department of Health and Human Services and Health-related line items H.R. 6201: Families First Coronavirus Response Act; provisions related to the Department of Health and Human Services and Health-related line items Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 110:Medical Expense Savings Act; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 3630: No Surprises Act; all provisions H.R. 4100: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
S. 110:Medical Expense Savings Act; all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
H.R. 2113: Prescription Drug STAR Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 19: Lower Costs, More Cures Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: More Efficient Tools to Realize Information for Consumers Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 3630: No Surprises Act; all provisions H.R. 4698: Medical Records Access Fairness Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions Draft Legislation related to 21st Century Cures Act 2.0; all provisions Antibiotic Development Incentives discussions; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 110:Medical Expense Savings Act; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1531: Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions Antibiotic Development Incentives discussions; all provisions
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions H.R. 19: Lower Costs, More Cures Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2113: Prescription Drug STAR Act; all provisions H.R. 2296: More Efficient Tools to Realize Information for Consumers Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 2543: Prescription Drug Pricing Reduction Act of 2019; all provisions
H.R. 1865: Further Consolidated Appropriations Act, 2020; provisions related to funding for the Health and Human Services, Food and Drug Administration, and related agencies H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Further Continuing Appropriations Act, 2020, and Further Health Extenders Act of 2019; provisions related to funding for the Food and Drug Administration and related agencies H.R. 3164: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies H.R. 4378: Continuing Appropriations Act, 2020, and Health Extenders Act of 2019; provisions related to funding for the Health and Human Services and related agencies S. 2522: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies (Draft) Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020; provisions related to funding for the Health and Human Services and related agencies
S. 110:Medical Expense Savings Act; all provisions
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 2113: Prescription Drug STAR Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies H.R. 4378 - Continuing Appropriations Act, 2020, and Health Extenders Act of 2019; provisions related to funding for the Health and Human Services, Food and Drug Administration and related agencies S. 2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020 draft; provisions related to funding for the Health and Human Services and related agencies
General discussions regarding Medical Deferred Action
H.R. 3: Lower Drug Costs Now Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies H.R. 4378 - Continuing Appropriations Act, 2020, and Health Extenders Act of 2019; provisions related to funding for the Health and Human Services and related agencies S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020 draft; provisions related to funding for the Health and Human Services and related agencies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.J. Res. 74: Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions H.R. 3 - Lower Drug Costs Now Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S.J. Res. 52: A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury and the Secretary of Health and Human Services relating to "State Relief and Empowerment Waivers"; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions The Medical Records Access Fairness Act draft; all provisions
H.R. 2113: Prescription Drug STAR Act; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions
H.R. 3: Lower Drug Costs Now Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies H.R. 4378 - Continuing Appropriations Act, 2020, and Health Extenders Act of 2019; provisions related to funding for the Health and Human Services and related agencies S. 2158: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions S. 2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020 draft; provisions related to funding for the Health and Human Services and related agencies
General discussions regarding Medical Deferred Action
H.R. 3: Lower Drug Costs Now Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2113: Prescription Drug STAR Act; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 2543 - Prescription Drug Pricing Reduction Act of 2019; all provisions
H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies H.R. 4378 - Continuing Appropriations Act, 2020, and Health Extenders Act of 2019; provisions related to funding for the Health and Human Services, Food and Drug Administration and related agencies S. 2522 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020 draft; provisions related to funding for the Health and Human Services and related agencies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 2113: Prescription Drug STAR Act; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions
H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 987: Strengthening Health Care and Lowering Prescription Drug Costs Act; all provisions H.R. 1010: To provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect; all provisions H.R. 1425: State Health Care Premium Reduction Act; all provisions H.R. 1868: Health Care Affordability Act of 2019; all provisions H.R. 1870: Family Health Care Affordability Act of 2019; all provisions H.R. 2296: FAIR Drug Pricing Act of 2019; all provisions H.R. 2507: Newborn Screening Saves Lives Reauthorization Act of 2019; all provisions Ways & Means and Energy & Commerce discussion draft on capping Medicare Part D out-of-pocket costs; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions S. 961: Improving Health Insurance Affordability Act of 2019; all provisions S. 1556: No Junk Plans Act; all provisions S. 1712: Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; all provisions S. 1895: Lower Health Care Costs Act; all provisions S. 1935: Family Coverage Act; all provisions
H.R. 2740: Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; provisions related to funding for the Health and Human Services and related agencies H.R. 3055: Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; provisions related to funding for the Food and Drug Administration and related agencies Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020; provisions related to funding for the Health and Human Services and related agencies Fiscal Year 2020 Agriculture Appropriations; provisions related to funding for the Food and Drug Administration and related agencies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 861: End Surprise Billing Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1226: Advancing Care for Exceptional Kids (ACE) Act of 2019; all provisions S. 317: Advancing Care for Exceptional Kids (ACE) Act of 2019; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions Discussion Draft: Energy and Commerce Proposals to Strengthen Pre-existing Conditions Protections and Lower Health Care Costs; all provisions
H.R. 265: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; provisions related to funding for the Food and Drug Administration and related agencies H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions H.R. 1499: Protecting Consumer Access to Generic Drugs Act of 2019; all provisions H.J.Res.28: Further Additional Continuing Appropriations Act, 2019; provisions related to the Department of Health and Human Services and related agencies S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions Labor, Health and Human Services (LHHS) appropriations for Fiscal Year 2020; all provisions Fiscal Year 2020 Agriculture Appropriations; provisions related to funding for Food and Drug Administration and related agencies (No Bill Number) Newborn Screening Saves Lives Act; all provisions (No Bill Number) Organ Procurement Optimization Act; all provisions
H.R. 861: End Surprise Billing Act of 2019; all provisions H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions H.R. 986: Protecting Americans with Preexisting Conditions Act of 2019; all provisions H.R. 1010: To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect; all provisions H.R. 1226: Advancing Care for Exceptional Kids (ACE) Act of 2019; all provisions H.R. 1499: Protecting Consumer Access to Generic Drugs Act of 2019; all provisions S. 317: Advancing Care for Exceptional Kids (ACE) Act of 2019; all provisions S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019; all provisions S. 466: Protecting Americans with Pre-existing Conditions Act of 2019; all provisions S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions Discussion Draft: Energy and Commerce Proposals to Strengthen Pre-existing Conditions Protections and Lower Health Care Costs; all provisions
S. 475: Reducing Existing Costs Associated with Pharmaceuticals for Seniors (RxCAP) Act of 2019; all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies
S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9936-NC: Provisions related to section 1332 of the Patient Protection and Affordable Care Act (PPACA) - State Relief and Empowerment Waivers
H.R. 2: Agriculture Improvement Act of 2018; provisions related to Association Health Plans H.R. 7295: Medial Records Access Fairness Act; all provisions S. 3042: Agriculture Improvement Act of 2018; provisions related to Association Health Plans S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9936-NC: Provisions related to section 1332 of the Patient Protection and Affordable Care Act (PPACA) - State Relief and Empowerment Waivers
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies H. R. 6157: Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Health Resources and Services Administration, the Social Security Administration and continuing Food and Drug Administration funding S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration and related agencies S. 3158: Departments of Labor, Health and Human Services, and Education and Related Agencies, Appropriations Act, 2019; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Health Resources and Services Administration, the Social Security Administration and continuing Food and Drug Administration funding
H.R. 2: Agriculture Improvement Act of 2018; provisions related to Association Health Plans H.R. 2587: Medical Nutrition Equity Act of 2017; all provisions H.R. 3325: Advancing Care for Exceptional (ACE) Kids Act; All provisions H.R. 6261: Improving Choices in Health Care Coverage Act; All provisions S. 428: ACE Kids Act of 2017; all provisions S. 1194: Medical Nutrition Equity Act of 2017; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions S. 3042: Agriculture Improvement Act of 2018; provisions related to Association Health Plans S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions H.J. Res. 140 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, the Department of Labor, and the Department of Health and Human Services relating to "Short-Term, Limited-Duration Insurance; all provisions S.J. Res. 63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance"; all provisions Draft Bill: To amend the HITECH Act to allow an individual to obtain a copy of such individuals protected health information at no cost in certain circumstances, and for other purposes; all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-1693-P: Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program, and Medicaid Promoting Interoperability Program.; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9920-F: Adoption of Methodology for HHS-operated Permanent Risk Adjustment Program under the Patient Protection and Affordable Care Act for the 2017 Benefit Year; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9924-F: Short-term, Limited-Duration Insurance; all provisions Centers for Medicare & Medicaid Services Health Plan Management System Memo Re: Prohibition on Imposing Mandatory Step Therapy for Access to Part B Drugs and Services; all provisions Centers for Medicare & Medicaid Services - Section 1332: State Innovation Waivers; Provisions regarding Michigans Waiver Application Centers for Medicare & Medicaid Services - Section 1332: State Innovation Waivers; Provisions regarding New Hampshires Waiver Application Centers for Medicare & Medicaid Services - Section 1115: State Innovation Waivers; Provisions regarding Kentuckys Health Waiver Application work requirements to Medicaid
H.R. 2: Agriculture Improvement Act of 2018; provisions related to Association Health Plans H.R. 2587: Medical Nutrition Equity Act of 2017; all provisions H.R. 3325: Advancing Care for Exceptional (ACE) Kids Act; All provisions H.R. 6261: Improving Choices in Health Care Coverage Act; All provisions S. 428: ACE Kids Act of 2017; all provisions S. 1194: Medical Nutrition Equity Act of 2017; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions S. 3042: Agriculture Improvement Act of 2018; provisions related to Association Health Plans S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions H.J. Res. 140 - Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Department of the Treasury, the Department of Labor, and the Department of Health and Human Services relating to "Short-Term, Limited-Duration Insurance; all provisions S.J. Res. 63 - A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Secretary of the Treasury, Secretary of Labor, and Secretary of Health and Human Services relating to "Short-Term, Limited Duration Insurance"; all provisions Draft Bill: To amend the HITECH Act to allow an individual to obtain a copy of such individuals protected health information at no cost in certain circumstances, and for other purposes; all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-1693-P: Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program, and Medicaid Promoting Interoperability Program.; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9920-F: Adoption of Methodology for HHS-operated Permanent Risk Adjustment Program under the Patient Protection and Affordable Care Act for the 2017 Benefit Year; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-9924-F: Short-term, Limited-Duration Insurance; all provisions Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding Michigans Waiver Application Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding New Hampshires Waiver Application Centers for Medicare & Medicaid Services - Section 1115: State Innovation Waivers; Provisions regarding Kentuckys Health Waiver Application work requirements to Medicaid
H.R. 2587: Medical Nutrition Equity Act of 2017; all provisions H.R. 3325: Advancing Care for Exceptional (ACE) Kids Act; All provisions S. 428: ACE Kids Act of 2017; all provisions S. 1194: Medical Nutrition Equity Act of 2017; all provisions S. 3388: Ensuring Coverage for Patients with Pre-Existing Conditions Act; all provisions Centers for Medicare & Medicaid Services Regulation# CMS-1693-P: Medicare Program: Revisions to Payment Policies under the Physician Fee Schedule and Other Revisions to Part B for CY 2019; Medicare Shared Savings Program Requirements; Quality Payment Program, and Medicaid Promoting Interoperability Program.; all provisions Centers for Medicare & Medicaid Services - Section 1332: State Innovation Waivers; Provisions regarding Michigans Waiver Application Centers for Medicare & Medicaid Service - Section 1115: State Innovation Waivers; Provisions regarding Kentuckys Waiver Application work requirements to Medicaid Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding New Jerseys Waiver Application-Reinsurance Centers for Medicare & Medicaid Service - Section 1115: State Innovation Waivers; Provisions regarding Utahs Waiver Application work requirements to Medicaid
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 878: Right to Try Act 2017; all provisions H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; all provisions H.R. 5385: Childrens Hospital GME Support Reauthorization Act of 2018; All provisions S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions S. 2597: Childrens Hospital GME Support Reauthorization Act of 2018; All provisions No Bill Yet Introduced: Ideas to Make Health Care Affordable Again (Senator Cassidys White Paper); all provisions of draft No Bill Yet Introduced: American Patients First - The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-9924-P: Short-term, Limited-Duration Insurance; all provisions Employee Benefits Security Administration Regulation# RIN 1210-AB85: Definition of Employer Under Section 3 (5) of ERISA - Association Health Plans; all provisions Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding Wisconsins Waiver Application Discussions related to Medicaid and Insurance Markets
No Bill Yet Introduced: Ideas to Make Health Care Affordable Again (Senator Cassidys White Paper); all provisions of draft
H. R. 3: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2979: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions No Bill Yet Introduced: Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and Social Security Administration No Bill Yet Introduced: Establishing the congressional budget for the United Sates Government for the fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028; Provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration
S. 2507: Improving Choices in Health Care Coverage Act; all provisions No Bill Yet Introduced: Ideas to Make Health Care Affordable Again (Senator Cassidys White Paper); all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-9924-P: Short-term, Limited-Duration Insurance; all provisions Employee Benefits Security Administration Regulation# RIN 1210-AB85: Definition of Employer Under Section 3 (5) of ERISA - Association Health Plans; all provisions
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 878: Right to Try Act 2017; all provisions H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; all provisions H.R. 5385: Childrens Hospital GME Support Reauthorization Act of 2018; All provisions S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions S. 2597: Childrens Hospital GME Support Reauthorization Act of 2018; All provisions No Bill Yet Introduced: Ideas to Make Health Care Affordable Again (Senator Cassidys White Paper); all provisions of draft No Bill Yet Introduced: American Patients First - The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs; all provisions of draft Centers for Medicare & Medicaid Services Regulation# CMS-9924-P: Short-term, Limited-Duration Insurance; all provisions Employee Benefits Security Administration Regulation# RIN 1210-AB85: Definition of Employer Under Section 3 (5) of ERISA - Association Health Plans; all provisions Centers for Medicare & Medicaid Service - Section 1332: State Innovation Waivers; Provisions regarding Wisconsins Waiver Application Discussions related to Medicaid and Insurance Markets
H. R. 3: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2979: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions No Bill Yet Introduced: Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and Social Security Administration No Bill Yet Introduced: Establishing the congressional budget for the United Sates Government for the fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028; Provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration
H. R. 3: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions H. R. 5961: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2976: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2019; All provisions related to funding for Food and Drug Administration S. 2979: Spending Cuts to Expired and Unnecessary Programs Act; Provisions related to Childrens Health Insurance Program rescissions No Bill Yet Introduced: Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes; Provisions related to funding for National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration No Bill Yet Introduced: Establishing the congressional budget for the United Sates Government for the fiscal year 2019 and setting forth the appropriate budgetary levels for fiscal years 2020 through 2028; Provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
H.R. 3325: ACE Kids Act; all provisions H.R. 3921: HEALTHY KIDS Act; all provisions H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions S. 428: ACE Kids Act of 2017; all provisions S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions S. 2052: Health Care Market Certainty and Mandate Relief Act; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2018; all provisions
H.R. 3325: ACE Kids Act; all provisions S. 428: ACE Kids Act of 2017; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2018; all provisions
H.R. 878: Right to Try Act 2017; all provisions H.R. 3325: ACE Kids Act; all provisions H.R. 3921: HEALTHY KIDS Act; all provisions H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions H.R. 5247: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018; all provisions S. 204: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017; all provisions S. 428: ACE Kids Act of 2017; all provisions S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions S. 2052: Health Care Market Certainty and Mandate Relief Act; all provisions S. 2507: Improving Choices in Health Care Coverage Act; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2018; all provisions
H. R. 195: Making Further Continuing Appropriations for the Fiscal Year Ending September 30, 2018, and For Other Purposes; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1625: Consolidated Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration and potential inclusion of marketplace stabilization language H.R. 1892: Bipartisan Budget Act of 2018; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, the Social Security Administration and potential inclusion of marketplace stabilization language
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction H.R. 3922: CHAMPIONING HEALTHY KIDS Act; all provisions H.R. 4200: Healthcare Market Certainty and Mandate Relief Act of 2017; all provisions H.R. 4695: Bipartisan Market Stabilization and Innovation Act of 2017; all provisions S. 1: An original bill to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction S. 1827: Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017; all provisions S. 1835: Lower Premiums Through Reinsurance Act of 2017; all provisions S. 2052: Health Care Market Certainty and Mandate Relief Act of 2017; all provisions No Bill Yet Introduced: Bipartisan Health Care Stabilization Act of 2017; all provisions
H.J. Res. 123: Making further continuing appropriations for fiscal year 2018, and for other purposes; provisions related to funding for the Childrens Health Insurance Program (CHIP), Food and Drug Administration, and the National Institutes of Health H.R. 601: Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1370: An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes; provisions related to Childrens Health Insurance Program (CHIP) and pay-as-you-go (PAYGO), National Institutes of Health, and the Food and Drug Administration H.R. 3268: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration H.R. 3354: Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018: provisions related to funding for Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration S. 1603: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration
H.R. 1: An Act to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction S. 1: An original bill to provide for reconciliation pursuant to title II of the concurrent resolution on the budget for fiscal year 2018; provisions related to individual mandate repeal, Orphan Drug Tax Credit, Medical Expenses Deduction
H.J. Res. 123: Making further continuing appropriations for fiscal year 2018, and for other purposes; provisions related to funding for the National Institutes of Health, Childrens Health Insurance Program, and the Food and Drug Administration H.R. 601: Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 1370: An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes; provisions related to Childrens Health Insurance Program (CHIP) and pay-as-you-go (PAYGO), National Institutes of Health, and the Food and Drug Administration H.R. 3354: Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018: provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
H.R. 601: Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017; provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 3354: Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018: provisions related to funding for the Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 3358: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; provisions related to funding for the National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration S. 1771: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; provisions related to funding for the National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
H.R. 601: Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017; provisions related to funding for the Food and Drug Administration, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 3268: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration H.R. 3354: Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018: provisions related to funding for Food and Drug Administration, National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration H.R. 3358: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; provisions related to funding for the National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration S. 1603: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2018; provisions related to funding for the Food and Drug Administration S. 1771: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018; provisions related to funding for the National Institutes of Health, Centers for Disease Control, Agency for Healthcare Research and Quality, Maternal and Child Health Bureau grants, Health Resources and Services Administration, and the Social Security Administration
H.R. 1628: American Health Care Act of 2017/Better Care Reconciliation Act (Senate); and Graham-Cassidy-Heller-Johnson proposed amendment (S. Amdt. 1030); all provisions S. 1569: A bill to amend the Public Health Service Act to eliminate the non-application of certain State waiver provisions to Members of Congress and congressional staff. (Better Care Reconciliation Act); all provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Discussions related to National Institutes of Health (NIH) and Food and Drug Administration (FDA) funding Discussions related to Potential Health Care Reform Legislation in the 115th Congress; provisions related to protections for people with pre-existing conditions, Medicaid financing, Medicaid expansion, high risk pools, annual and lifetime caps on coverage, consumer directed plans, and protections for provisions pertinent to the Cystic Fibrosis community Discussions related to general health care reform issues and considerations relative to the Cystic Fibrosis community in response to Speaker Ryans Better Way Plan and Representative Prices Empowering Patients First Act; provisions related to coverage for pre-existing conditions, high risk pools, consumer directed health plans, annual and lifetime coverage caps, Medicaid financing and expansion Discussions related to the Affordable Care Act Reform Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HR 209: Ensuring Access to Clinical Trials Act of 2015; provisions related to access S. 139: Ensuring Access to Clinical Trials Act of 2015; provisions related to access Docket No: FDA-2014-N-2187: Identifying Potential Biomarkers of Qualifications and Describing Contexts of Use to Address Areas Important to Drug Development; provided regulatory comments on issue
HR 6: 21st Century Cures Act; provisions on drug development and disease research HR 209: Ensuring Access to Clinical Trials Act of 2015; provisions related to access Not Yet Introduced: Discussions related to HELP Innovation for Healthier Americans legislation; provisions on drug development and disease research Not Yet Introduced: Discussions related to Hawaii Cystic Fibrosis Care Center; provisions related to access to military health care center for civilians with Cystic Fibrosis
HR 605: Medicare Home Infusion Site of Care Act of 2015; all provisions of the bill Department of Health and Human Services-Rule CMS-2333-P: Mental Health Parity and Addiction Equity Act of 2008; the Application to Medicaid Managed Care, CHIP, and Alternate Benefits Plans; provided regulatory comments on issue
HR 1770: Data Security and Breach Notification Act of 2015; provisions related to information security and breach notice requirements
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care
research funding, rare disease awareness, HR 2866 the Improving Access to Clinical Trials Act, HR 2965 Reauthorizing the Small Business Innovation and Research Act, food and drug safety, access to medical care